The Journal of Allergy and Clinical Immunology
Volume 125, Issue 3 , Pages 559-562 , March 2010

Advances in environmental and occupational respiratory diseases in 2009

  • David B. Peden, MD

      Affiliations

    • Division of Pediatric Allergy, Immunology Rheumatology and Infectious Diseases and the Center for Environmental Medicine, Asthma, and Lung Biology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • Corresponding Author InformationReprint requests: David B. Peden, MD, Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina School of Medicine, EPA Human Studies Facility, 104 Mason Farm Road, CB# 7310, Chapel Hill, NC 27599.
    • ,
  • Robert K. Bush, MD

      Affiliations

    • Section of Allergy, Immunology, Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Wisconsin, Madison, Wis

Received 5 January 2010 ,Accepted 6 January 2010.

References 

  1. Grönlund H, Adedoyin J, Commins SP, Platts-Mills TAE, van Hage M. The carbohydrate galactose-alpha-1,3-galactose is a major IgE-binding epitope on cat IgA. J Allergy Clin Immunol. 2009;123:1189–1191
  2. Mattsson L, Lundgren T, Everberg H, Larsson H, Lidholm J. Prostatic kallikrein: a new major dog allergen. J Allergy Clin Immunol. 2009;123:362–368
  3. Ayuso R, Grishina G, Ibanez MD, Blanco C, Carrillo T, Bencharitiwong R, et al. Sarcoplasmic calcium-binding protein is an EF-hand-type protein identified as a new shrimp allergen. J Allergy Clin Immunol. 2009;124:114–120
  4. Ohgiya Y, Arakawa F, Akiyama H, Yoshioka Y, Hayashi Y, Sakai S, et al. Molecular cloning, expression, and characterization of a major 38-kd cochineal allergen. J Allergy Clin Immunol. 2009;123:1157–1162
  5. Dykewicz MS. Occupational asthma: current concepts in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2009;123:519–528
  6. Krop EJM, Heederik DJJ, Lutter R, De Meer G, Aalberse RC, Jansen HM, et al. Associations between pre-employment immunologic and airway mucosal factors and the development of occupational allergy. J Allergy Clin Immunol. 2009;123:694–700
  7. Malo JL, Chan-Yeung M. Agents causing occupational asthma. J Allergy Clin Immunol. 2009;123:545–550
  8. Gill BV, Rice TR, Cartier A, Gautrin D, Neis B, Horth-Susin L, et al. Identification of crab proteins that elicit IgE reactivity in snow crab-processing workers. J Allergy Clin Immunol. 2009;124:1055–1061
  9. Maestrelli P, Boschetto P, Fabbri LM, Mapp CE. Mechanisms of occupational asthma. J Allergy Clin Immunol. 2009;123:531–542
  10. Takeda N, Maghni K, Daigle S, L'Archeveque J, Castellanos L, Al Ramli W, et al. Long-term pathologic consequences of acute irritant-induced asthma. J Allergy Clin Immunol. 2009;124:975–981
  11. Smith AM, Bernstein DI. Management of work-related asthma. J Allergy Clin Immunol. 2009;123:551–557
  12. Walgraffe D, Matteotti C, el Bakkoury M, Garcia L, Marchand C, Bullens D, et al. A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines. J Allergy Clin Immunol. 2009;123:1150–1156
  13. Roesler E, Weiss R, Weinberger EE, Fruehwirth A, Stoecklinger A, Mostbock S, et al. Immunize and disappear-Safety-optimized mRNA vaccination with a panel of 29 allergens. J Allergy Clin Immunol. 2009;124:1070–1077
  14. Hofmann AM, Scurlock AM, Jones SM, Palmer KP, Lokhnygina Y, Steele PH, et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol. 2009;124:286–291
  15. Jones SM, Pons L, Roberts JL, Scurlock AM, Perry TT, Kulis M, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol. 2009;124:292–300
  16. Maintz L, Bussmann C, Bieber T, Novak N. Contribution of histamine metabolism to tachyphylaxis during the buildup phase of rush immunotherapy. J Allergy Clin Immunol. 2009;123:701–703
  17. Scranton SE, Gonzalez EG, Waibel KH. Incidence and characteristics of biphasic reactions after allergen immunotherapy. J Allergy Clin Immunol. 2009;123:493–498
  18. Ronmark E, Bjerg A, Perzanowski M, Platts-Mills T, Lundback B. Major increase in allergic sensitization in schoolchildren from 1996 to 2006 in northern Sweden. J Allergy Clin Immunol. 2009;124:357–363
  19. Erwin EA, Hosen J, Pollart SM, Reid MJ, Platts-Mills TA. High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE. J Allergy Clin Immunol. 2009;123:706–708
  20. Balmes JR, Earnest G, Katz PP, Yelin EH, Eisner MD, Chen H, et al. Exposure to traffic: lung function and health status in adults with asthma. J Allergy Clin Immunol. 2009;123:626–631
  21. Zock JP, Plana E, Anto JM, Benke G, Blanc PD, Carosso A, et al. Domestic use of hypochlorite bleach, atopic sensitization, and respiratory symptoms in adults. J Allergy Clin Immunol. 2009;124:731–738
  22. Lopez-Souza N, Favoreto S, Wong H, Ward T, Yagi S, Schnurr D, et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol. 2009;123:1384–1390
  23. Rueff F, Przybilla B, Bilo MB, Muller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124:1047–1054
  24. Pieretti MM, Chung D, Pacenza R, Slotkin T, Sicherer SH. Audit of manufactured products: use of allergen advisory labels and identification of labeling ambiguities. J Allergy Clin Immunol. 2009;124:337–341
  25. Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123:672–679
  26. Haselkorn T, Fish JE, Zeiger RS, Szefler SJ, Miller DP, Chipps BE, et al. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol. 2009;124:895–902
  27. Appleton SL, Ruffin RE, Wilson DH, Taylor AW, Adams RJ. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists. J Allergy Clin Immunol. 2009;123:124–130
  28. Sampson HA. Role of complementary and alternative medicine in the field of allergy and clinical immunology. J Allergy Clin Immunol. 2009;123:317–318
  29. Engler RJ, With CM, Gregory PJ, Jellin JM. Complementary and alternative medicine for the allergist-immunologist: where do I start?. J Allergy Clin Immunol. 2009;123:309–316
  30. Mainardi T, Kapoor S, Bielory L. Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol. 2009;123:283–294
  31. Li XM, Brown L. Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy. J Allergy Clin Immunol. 2009;123:297–306

 R.B. received grant support from the National Institutes of Health and Greer Laboratories, Lenoir, NC

 Disclosure of potential conflict of interest: D. B. Peden is a consultant to GlaxoSmthKline and Funcxional Therapeutics. R. K. Bush has declared that he has no conflict of interest.

PII: S0091-6749(10)00009-6

doi: 10.1016/j.jaci.2010.01.004

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 3 , Pages 559-562 , March 2010

Article Tools